Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial

被引:36
作者
Bruix, J. [1 ]
Merle, P. [2 ]
Granito, A. [3 ]
Huang, Y. -H. [4 ,5 ]
Bodoky, G. [6 ]
Yokosuka, O. [7 ]
Rosmorduc, O. [8 ,9 ]
Breder, V. [10 ]
Gerolami, R. [11 ]
Masi, G. [12 ]
Paul, J. Ross [13 ]
Qin, S. [14 ]
Song, T. [15 ]
Bronowicki, J. -P. [16 ]
Ollivier-Hourmand, I. [17 ]
Kudo, M. [18 ]
LeBerre, M. -A. [19 ]
Baumhauer, A. [20 ]
Meinhardt, G. [21 ]
Han, G. [22 ]
机构
[1] Univ Barcelona, Hosp Clin, BCLC Grp, Liver Unit, Barcelona, Spain
[2] Grt Hosp Lyon Nord, Hepatol Unit, Lyon, France
[3] Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Bologna, Italy
[4] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[5] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[6] St Laszlo Teaching Hosp, Budapest, Hungary
[7] Chiba Univ, Dept Gastroenterol & Nephrol, Chiba, Japan
[8] Hop La Pitie Salpetriere, Dept Hepatol, AP HP, Paris, France
[9] Univ Paris 06, Sorbonne Univ, Paris, France
[10] Russian Canc Res Ctr, Moscow, Russia
[11] Univ Aix Marseille 2, CHU Timone, Marseille, France
[12] Azienda Osped Univ Pisana, Pisa, Italy
[13] Kings Coll Hosp NHS Fdn Trust, London, England
[14] Nanjing Bayi Hosp, Chinese Peoples Liberat Army Canc Ctr, Nanjing, Jiangsu, Peoples R China
[15] Tianjin Med Univ, Canc Hosp, Tianjin, Peoples R China
[16] Univ Lorraine, CHU Nancy, INSERM 954, Nancy, France
[17] CHU, Serv Hepatogastroenterol, Caen, France
[18] Kindai Univ, Fac Med, Osaka, Japan
[19] Bayer HealthCare SAS, Loos, France
[20] Bayer Vital GmbH, Bayer Pharmaceut, Leverkusen, Germany
[21] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[22] Fourth Mil Med Univ, Affiliated Hosp 1, Xian, Peoples R China
关键词
D O I
10.1093/annonc/mdw237.03
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:140 / +
页数:2
相关论文
empty
未找到相关数据